Cadence Pharmaceuticals, Inc. Reports Third Quarter 2012 Financial Results

SAN DIEGO, Nov. 5, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the third quarter and nine months ended September 30, 2012.

Back to news